CINCINNATI - Researchers report in the journal Cancer Cell an experimental therapy that in laboratory tests on human cells and mouse models stops aggressive, treatment-resistant and deadly brain cancers called glioblastoma and high-grade gliomas.
A multi-institutional team led by researchers at Cincinnati Children's Hospital Medical Center publishes their results on May 9.